British minister Dehenna Davison recently resigned from government, explaining that chronic migraines were making it impossible for her to do her job. Her announcement coincided with a new drug for acute migraines being recommended for use in the NHS. Madeleine Finlay meets Prof Peter Goadsby, whose pioneering research underpins the new drug, to find out about the advances we’ve made in understanding migraines, and whether we might one day be able to wave goodbye to migraines for good. Help support our independent journalism at <a href="https://www.theguardian.com/sciencepod">theguardian.com/sciencepod</a>
